Ab Science

The sponsor maintains a significant focus on developing treatments for various forms of cancer, with particular emphasis on hematological malignancies and solid tumors. Research activities encompass advanced-stage cancers requiring novel therapeutic approaches, including conditions where conventional treatment options have been exhausted.

• Acute Myeloid Leukemia
• Gastrointestinal Stromal Tumors
• Pancreatic Cancer
• Prostate Cancer

The organization's oncology portfolio demonstrates commitment to addressing both rare and more prevalent cancer types, with investigations spanning multiple lines of therapy and patient populations with limited treatment alternatives.